Diagnostic News and Research

RSS

HDL to acquire Harris Scientific

Health Diagnostic Laboratory Inc., a CAP accredited leader in health management, announced today that it will expand its comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases through the acquisition of Harris Scientific, Inc., a company providing omega-3 fatty acid testing based on the research of Dr. William Harris.

25 May 2011

Exosome Diagnostics announces expansion of scientific advisory board

Exosome Diagnostics, a leading developer of biofluid based molecular diagnostic tests for use in personalised medicine, today announced the appointments of Bob Carter MD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board (SAB).

24 May 2011

Nestle Health Science to acquire Prometheus Laboratories

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has entered into a definitive agreement to be acquired by Nestle Health Science S.A., a wholly-owned subsidiary of Nestle S.A., for an undisclosed amount.

24 May 2011

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

Cinterion, the global leader in cellular machine-to-machine communication modules and a Gemalto company, and TZ Medical, a leading manufacturer of critical-care medical products, today announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device.

24 May 2011

Scientists discover genetic regions that affect severity of cystic fibrosis

A team of international researchers, including Case Western Reserve University School of Medicine, have discovered regions of the genome that affect the severity of the genetic disease cystic fibrosis, the most common lethal genetic disease affecting children in North America.

24 May 2011

Practical solutions for translational science from Randox Laboratories

The sole purpose of translational science is to transfer scientific discoveries made in ‘basic research’ to clinical reality, to improve the health of individuals and reduce suffering.

From Randox Laboratories Ltd. 23 May 2011

New technique can detect minute traces of tumoral DNA in biological fluids

It will perhaps be possible, in the near future, to detect cancer by a simple blood or urine test. In fact, biologists from CNRS, Inserm, Paris Descartes and Strasbourg universities have developed a technique capable of detecting minute traces of tumoral DNA present in the biological fluids of patients suffering from cancer.

23 May 2011

Morris Hospital installs Toshiba's Ultimax X-ray system to streamline diagnosis, improve patient throughput

Advancements in diagnostic imaging technology are enabling healthcare facilities to achieve multifunctional capabilities using a single modality. To streamline diagnosis and improve patient throughput, Morris Hospital has installed the Ultimax X-ray system from Toshiba America Medical Systems, Inc.

23 May 2011

Welch Allyn announces availability of co-branded Health o meter Professional Scales in Europe

Welch Allyn, a leading global provider of medical diagnostic equipment, announced today that its co-branded Health o meter Professional Scales are now available in Europe.

23 May 2011

Lab21 acquires molecular diagnostics company Myconostica Ltd

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has today announced that it has acquired Myconostica Ltd, a molecular diagnostic company focussing on the diagnosis of fungal infections of clinical importance.

23 May 2011

First nucleic acid amplification test to diagnose early stages of Q fever infections receives FDA approval

The U.S. Food and Drug Administration today cleared the first nucleic acid amplification test to diagnose the early stages of Q fever infections in military personnel serving overseas.

21 May 2011

Stony Brook University CFB establishes Biotechnology Commercialization Fund

The Center for Biotechnology (CFB) at Stony Brook University has established the Biotechnology Commercialization Fund to accelerate the development of promising biomedical technologies emerging from Stony Brook University.

21 May 2011

Researchers develop cheap, reliable diagnostic test for HLRCC

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this type of cancer.

21 May 2011

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

Gen-Probe Incorporated announced today that the Company has filed a 510(k) application with the US Food and Drug Administration for its PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.

20 May 2011

VIDAS TOXO IgG Avidity assay to test for recent Toxoplasma gondii infection receives FDA clearance

On May 18, the U.S. Food and Drug Administration cleared the first test to help determine whether a pregnant woman or a person with swollen lymph nodes testing positive for toxoplasmosis, sometimes known as cat scratch disease, developed the infection within the past four months.

20 May 2011

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Mitomics, world leader in the research and development of mitochondrial genome-based products, today announced it has entered into a non-exclusive licensing agreement with QDx Pathology Services to develop, market and process the QPredict™ Prostate Mitomic Test.

19 May 2011

Thermo Fisher Scientific to acquire Phadia for €2.47 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.

From Thermo Fisher Scientific Inc. 19 May 2011

Sensitive troponin assays improve clinical outcome and cardiac patient management

Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary syndromes.

19 May 2011

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.

19 May 2011

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Abbott announced today that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), the leading cause of liver cancer in the United States.

19 May 2011

Diagnostic News and Research

HDL to acquire Harris Scientific

Exosome Diagnostics announces expansion of scientific advisory board

Nestle Health Science to acquire Prometheus Laboratories

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

Scientists discover genetic regions that affect severity of cystic fibrosis

Practical solutions for translational science from Randox Laboratories

New technique can detect minute traces of tumoral DNA in biological fluids

Morris Hospital installs Toshiba's Ultimax X-ray system to streamline diagnosis, improve patient throughput

Welch Allyn announces availability of co-branded Health o meter Professional Scales in Europe

Lab21 acquires molecular diagnostics company Myconostica Ltd

First nucleic acid amplification test to diagnose early stages of Q fever infections receives FDA approval

Stony Brook University CFB establishes Biotechnology Commercialization Fund

Researchers develop cheap, reliable diagnostic test for HLRCC

Gen-Probe seeks FDA regulatory clearance for PANTHER fully automated and integrated molecular testing system

VIDAS TOXO IgG Avidity assay to test for recent Toxoplasma gondii infection receives FDA clearance

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Thermo Fisher Scientific to acquire Phadia for €2.47 billion

Sensitive troponin assays improve clinical outcome and cardiac patient management

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News